All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong...

Published on 16 Jan 2024 on Zacks · via Yahoo Finance

All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong...

HOOKIPA Pharma Inc. (HOOK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.

Read the rest of the article

NASDAQ.HOOK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong...

NASDAQ.HOOK price evolution

Want to become a better investor?

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?

Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook

HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?

All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong...

Some Analysts Just Cut Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates

HOOKIPA Pharma Inc. (HOOK) Reports Q2 Loss, Lags Revenue Estimates

Revenue Downgrade: Here's What Analysts Forecast For HOOKIPA Pharma Inc. (NASDAQ:HOOK)

HOOKIPA Pharma Inc. (HOOK) Reports Q1 Loss, Lags Revenue Estimates

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2022 Earnings Call Transcript